Clinical/GLP FDA Standard Sequencing Service OverviewTo meet FDA regulatory requirements, the industry standard for Clinical/GLP DNA sequencing is only 4x bidirectional sequencing coverage of a given template. These minimal criteria can not always guarantee high quality, accurate sequencing information. To exceed regulatory requirements and client/sponsor expectations, SeqWright maintains a steadfast dedication to quality, rapid project turn-around, and client satisfaction which are complemented by an established, independent Quality Assurance Program which includes:
SeqWright takes great pride in its experience in, and understanding of, the science and regulatory requirements necessary for the characterization and reporting of Clinical/GLP sequencing data. We encourage all potential clients to schedule an on-site audit to inspect our Quality Assurance Program. Read about our client's recent FDA successes. Regulated Sequencing Service Features
Additional Regulatory Sequencing Services Available
Contact a sales representative about these services. |
||


